Since circulating LPS concentrations are reported to be in the ng/mL range in endotoxemia associated with metabolic diseases [15], our results suggest that LPS inhibition of insulin gene expression might occur in vivo in humans. The gene discussed is INS; the disease is Other metabolic disease.